We’re delighted to announce this joint virtual session with the National Cancer Research Institute (NCRI). Last year, we established a partnership with the NCRI to bring the immunology and cancer communities together to drive collaborations that address current challenges in immunotherapy through a series of joint initiatives, including this webinar.
This session will take place on Tuesday 17 November, 13:00 - 13:45 GMT. The session will focus on skin cancers (mainly malignant melanoma and Merkle cell carcinoma) and our understanding of the role that the immune system plays in their pathogenesis. The discussion will explore therapy resistance and consider the role of combination therapies – especially in the context of metastatic disease – deliberating key considerations in the preclinical and clinical settings. The discussion will explore key unanswered questions with a bench to bedside and back approach.
Speaker: Professor Lucie Heinzerling, University Hospital Erlangen, Germany
Chair: Dr Andrew Furness, The Royal Marsden NHS Foundation Trust, UK
Registration is free! Find out more and register here.